Exforge and Pvt - a phase IV clinical study of FDA data
Summary:
Pvt is reported only by a few people who take Exforge.
The study analyzes which people take Exforge and have Pvt. It is created by eHealthMe based on reports of 12,942 people who have side effects while taking Exforge from the FDA, and is updated regularly.
What is Exforge?
Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.
What is Pvt?
Pvt is found to be associated with 378 drugs and 741 conditions by eHealthMe. Check the latest studies of Pvt.
12,942 people reported to have side effects when taking Exforge.
Among them, 4 people (0.03%) have Pvt.

Among these 4 people:
What is the gender of people who have Pvt when taking Exforge? *
- female: 25 %
- male: 75 %
What is the age of people who have Pvt when taking Exforge? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
What are other drugs people take besides Exforge? *
- Novalgin: 3 people, 75.00%
- Euthyrox: 3 people, 75.00%
- Jakafi: 2 people, 50.00%
- Nexium: 1 person, 25.00%
- Methotrexate: 1 person, 25.00%
- Humira: 1 person, 25.00%
What are other side effects people have besides Pvt? *
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 75.00%
- Peripheral Swelling: 3 people, 75.00%
- Haematoma (collection of blood outside the blood vessels): 3 people, 75.00%
- Haemorrhagic Diathesis (bleeding tendency): 3 people, 75.00%
- Nasopharyngitis (inflammation of the nasopharynx): 3 people, 75.00%
- Nosebleed (bleeding from nose): 3 people, 75.00%
- Flatulence (flatus expelled through the anus): 3 people, 75.00%
- Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 3 people, 75.00%
- The Flu (the flu is caused by an influenza virus): 3 people, 75.00%
- Ascites (accumulation of fluid in the abdominal cavity): 2 people, 50.00%
What are the existing conditions these people have? *
- Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 75.00%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 25.00%
- Insomnia (sleeplessness): 1 person, 25.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 25.00%
- Gastritis (inflammation of stomach): 1 person, 25.00%
* Approximation only. Some reports may have incomplete information.
Do you take Exforge and have Pvt?
- Check whether Pvt is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Exforge:
- Exforge (13,350 reports)
Pvt treatments and more:
- Pvt (4,875 reports)
How severe was Pvt and when was it recovered:
Expand to all the drugs that have ingredients of amlodipine besylate; valsartan:
Sub-studies by age:
0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Exforge:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Pvt:
- Pvt (378 drugs)
Browse all the conditions that are associated with Pvt:
- Pvt (741 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on amlodipine besylate; valsartan (the active ingredients of Exforge) and Exforge (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cymbalta vs. Arava, side effect and effectiveness comparison - a second ago
- Methenamine Hippurate vs. Macrodantin, side effect and effectiveness comparison - 5 seconds ago
- Could Magnesium cause Post Procedural Haematoma? - 8 seconds ago
- Could Lithium Carbonate cause Sweating Increased? - 8 seconds ago
- Wellbutrin vs. Trintellix, side effect and effectiveness comparison - 13 seconds ago
- Could Zoloft cause Postoperative Infection? - 14 seconds ago
- Could Tramadol cause Hypertrophy? - 14 seconds ago
- Adderall and Renal Failure Acute for Men aged 40-49 - 15 seconds ago
- Adderall and Renal Failure for Men aged 40-49 - 16 seconds ago
- Adderall and Kidney Failure for Men aged 40-49 - 16 seconds ago